Morality Clinical Trial
Official title:
Azithromycine Pour la Vie Des Enfants au Niger - Implémentation et Recherche: Essai mortalité et résistance (Azithromycin for Child Survival in Niger: Programmatic Trial)
The MORDOR trial found that biannual distribution of azithromycin to children 1-59 months old reduced child mortality. The World Health Organization (WHO) released conditional guidelines for this intervention, which include targeting azithromycin distributions to children 1-11 months of age in high mortality settings. The proposed trial aims to demonstrate and evaluate large-scale implementation of azithromycin to children aged 1-11 months old in the context of a programmatic setting while monitoring mortality and resistance antimicrobial resistance.
In the Programmatic Trial, community health centers (also known as "CSIs" or "Centres de Santé Intégrés") will be randomized to one of two arms: 1) programmatic azithro 1-11: biannual oral azithromycin administration to children aged 1-11 months distributed by community health workers or 2) no intervention: no distribution of azithromycin. A total of 2,490 communities within selected CSIs will be included . All communities in both arms receive routine health services offered by community health workers working for the Niger Ministry of Health's community health program. Mortality will be monitored through birth histories. Mortality and morbidity will also be monitored using routinely collected community and clinic visit data. Antimicrobial resistance will be monitored in a subset of eligible CSIs. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03079726 -
Use of Device Data to Predict Frailty in Individuals
|
||
| Not yet recruiting |
NCT05447611 -
Role of Empathy in Curative Treatment Outcomes of Non-metastatic Colorectal Cancer.
|
||
| Completed |
NCT05268419 -
Efficacy and Safety of Ethanol Inhalation on COVID-19 Treatment (a Clinical Trial Study)
|
Phase 3 | |
| Completed |
NCT05042804 -
Perioperative Outcome Risk Assessment With Computer Learning Enhancement
|
N/A | |
| Recruiting |
NCT03628313 -
Valvular Aortic Stenosis Prognosis Study
|
||
| Completed |
NCT05527678 -
5 Years Quality of Life and Early Mobilization in ICU
|
||
| Recruiting |
NCT05088109 -
Shock Indices Use for Early Mortality From Septic Shock
|
||
| Recruiting |
NCT05073991 -
Incidence of Mortality and Complications After Lung Surgery, Open Thoracic Aortic Repair, TEVAR, EVAR.
|
||
| Completed |
NCT05844410 -
Evaluation of Corticosteroids Use and Clinical Outcomes in Hospitalized COVID-19 Patients: A Retrospective Study
|
||
| Recruiting |
NCT05585593 -
Registry for Hypoparathyroidism Wuerzburg
|
||
| Recruiting |
NCT03834246 -
Smoke Inhalation Injury in Patients Admitted to Intensive Care
|
||
| Completed |
NCT03919032 -
Bacterial Infections in Patients With Cirrhosis in Argentina: Clinical and Microbiological Characteristics
|
||
| Completed |
NCT05116670 -
Comparison of Care Practices, Mortality and Morbidity of Very Preterm Infants Between Two Tertiary Centers in Northwest and South of China
|
||
| Withdrawn |
NCT04531839 -
Improving Outcome of Very Preterm Infants Using Collaborative Quality Improvement
|
N/A | |
| Recruiting |
NCT04685278 -
Anticardiolipin Autoantibodies and Mortality in Septic Patients
|
||
| Completed |
NCT04049565 -
CRP Versus PCT as Bio-markers for Sepsis and in Guiding Antibiotics in Critically Ill Patients
|
||
| Not yet recruiting |
NCT03665987 -
The Effect of Preoperative Assessment Clinic on Prognosis and Economic Results of Patients With Coexisting Disease.
|
||
| Completed |
NCT04971278 -
Evaluating the Impact of a Supportive Care Program
|
||
| Recruiting |
NCT06087315 -
Evaluation of a Multi-country Medical Oxygen Program
|
||
| Completed |
NCT03344627 -
Clinical Outcome Study of High-dose Meropenem in Sepsis and Septic Shock Patients
|
N/A |